Form 4: Inari Medical Director Lucchese Reports Share Disposition Following Stryker Merger

Director Cynthia Lucchese reports the disposition of Inari Medical shares and derivative securities following the merger with Stryker Corporation, where each share was converted to $80.00 in cash.

Summary

• Cynthia Lucchese, a director of Inari Medical, filed a Form 4 detailing changes in beneficial ownership following the merger with Stryker Corporation.
• The merger, effective on February 19, 2025, resulted in Inari Medical becoming a wholly-owned subsidiary of Stryker.
• Each outstanding share of Inari Medical common stock was converted into the right to receive $80.00 in cash.
• Lucchese's holdings of common stock and restricted stock units (RSUs) were cancelled and converted into cash based on the merger consideration.
• Outstanding stock options were also cancelled and converted into the right to receive cash, calculated based on the difference between the merger consideration and the exercise price.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The merger provides a clear exit strategy for shareholders at a defined price. The document itself is a standard regulatory filing.

Positives

• The merger provided a cash payout of $80.00 per share for Inari Medical shareholders.

Future Outlook

The document does not contain any forward-looking statements beyond the completion of the merger.

Industry Context

This announcement reflects ongoing consolidation within the medical device industry, with larger players like Stryker acquiring innovative companies like Inari Medical to expand their product portfolios and market reach.

Comparison to Industry Standards

• The acquisition of Inari Medical by Stryker is comparable to other acquisitions in the medical device space, such as Boston Scientific's acquisition of BTG plc, which also aimed to expand their vascular and interventional product offerings.
• The $80 per share cash consideration is within the typical range observed in similar acquisitions of medical device companies with strong growth potential.

Stakeholder Impact

• Shareholders received $80.00 per share in cash.
• Employees of Inari Medical are now part of Stryker Corporation.

Key Dates

Keywords

Merger, Inari Medical, Stryker, Form 4, Beneficial Ownership, Lucchese, Acquisition